John L. Knopf, CEO and President at ACCELERON PHARMA INC (XLRN), sold 20,000 shares at $38.93 ($792K) on 2015-01-07, disclosed to the SEC on 2015-01-09.
Scheduled sale ($792k) by CEO and President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.93 | 1,200 | $47K | 5.9% |
| 2 | $39.66 | 18,800 | $746K | 94.1% |
| Total | $39.62 avg | 20,000 | $792K | 100% |
| Filing → |
| XLRN | SELL | 2016-05-20 | $3.3M | — | Filing → |
| XLRN | SELL | 2015-10-09 | $463K | — | Filing → |
| XLRN | SELL | 2015-09-10 | $574K | — | Filing → |